日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Oncolytic virus OVV-03 enhances CAR-T cell therapy against glioblastoma via immune modulation and specific HER2 upregulation.

溶瘤病毒OVV-03通过免疫调节和特异性HER2上调增强CAR-T细胞疗法对胶质母细胞瘤的疗效。

Tang Yi, E Qinzhi, Ma Liang, Li Xuetao, Zhang Yang, Wang Weichao, Jiang Zuoyu, Zhang Xuewen, Hou Yingbo, Du Jiaming, Zhu Yang, Dong Hanmiao, Xu Yeyang, Tian Ting, Cheng Longxin, Ma Qibin, Li Jian, Zhou Guoqing, Huang Yulun

TGF-β Blockade With SB525334 Enhances B7-H3 CAR-γδT Cell Efficacy Against Glioblastoma.

使用 SB525334 阻断 TGF-β 可增强 B7-H3 CAR-βT 细胞对胶质母细胞瘤的疗效。

Zhu Yang, Han Zijian, Zhou Zijing, Sui Yinqiang, Zhang Yang, Jiang Zuoyu, E Qinzhi, Zhang Xuewen, Wang Weichao, Hou Yingbo, Du Jiaming, Tang Yi, Dong Hanmiao, Xu Yeyang, Sun Ruoyu, Li Chenyang, Li Xuetao, Huang Yulun

Combined inhibition by PRMT5 and MAT2A demonstrates a strong synthetic lethality in MTAP homozygous-deficient glioma models.

PRMT5 和 MAT2A 的联合抑制在 MTAP 纯合缺陷型胶质瘤模型中表现出强烈的合成致死性

Jiang Zuoyu, Li Xuetao, Xiao Zongyu, Gan Wenjuan, Zhang Xuewen, Zhang Yang, Wang Weichao, E Qinzhi, Huang Yu, Shi Qikun, Tang Yi, Du Jiaming, Dong Hanmiao, Li Jian, Huang Yulun